Skip to main content
The Readout Loud (Podcast)

The Readout Loud (Podcast)

Audience metrics
  • Listenership
    1K-10K monthly listeners
  • Reviews
    4.7 (232 ratings)
Chart positions
Podcast details
  • Network
  • Language
    English
  • Genre
    Business
  • Location
    Boston
People
  • No profiles found.

Contact

Contact information
Get contact information for The Readout Loud (Podcast) and The Readout Loud (Podcast) journalists by joining Muck Rack.
Learn More
Website
https://soundcloud.com/readout-loud

Recent episodes

  • Jul 09, 2026 — Why does getting family health insurance through a job cost as much as buying a new car? How did a whistleblower take on an insurance contractor? And who might be the new Food and Drug Administration commissioner? We discuss all that and more on this...

    408: Whistleblower takes on health insurance and FDA commissioner candidates
  • Jun 25, 2026 — Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? Why are drugmakers spending so much money on acquisitions? And are hair loss drugs a good investment? We discuss all that and more on this week's episode of “The Readout...

    407: The mysterious case of Eli Lilly's obesity drug
  • Jun 18, 2026 — This week: New hope for people living with Huntington’s disease, and a report card on RFK Jr.’s effort to remake health in America. The Food and Drug Administration reversed its opposition to a closely watched gene therapy for Huntington’s disease,...

    406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises
  • Jun 11, 2026 — Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow greater access to experimental peptides? We discuss all that and more on this...

    405: An obesity drug deep-dive, and peptides move mainstream
  • Jun 04, 2026 — Why did oncologists give a standing ovation to a data presentation on Revolution Medicines' pancreatic cancer drug, daraxonrasib? Why did biotech stocks perform so badly this week? And are concrete beaches better than normal beaches? We discuss all...

    404: What RevMed's pancreatic cancer drug meant for one patient